Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients.
about
Granulysin-expressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescenceHuman immune response to Mycobacterium tuberculosis antigensPhagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses.Processing of Mycobacterium tuberculosis bacilli by human monocytes for CD4+ alphabeta and gammadelta T cells: role of particulate antigenPhenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis.Phosphorylated STAT3 and PD-1 regulate IL-17 production and IL-23 receptor expression in Mycobacterium tuberculosis infectionGeneration of CD8(+) T-cell responses to Mycobacterium bovis and mycobacterial antigen in experimental bovine tuberculosisDichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosisTemporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis.Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein.Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and class I MHC antigen cross processing by TLR9Expression of L-Selectin (CD62L), CD44, and CD25 on activated bovine T cells.Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis.Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.Cell-mediated immune responses in tuberculosis.Development of new vaccines and drugs for TB: limitations and potential strategic errorsT-cell-mediated protection of mice against virulent Mycobacterium tuberculosis.Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo.Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo.Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing mycobacterial hsp65.A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteinsDecreased expression of T-cell costimulatory molecule CD28 on CD4 and CD8 T cells of mexican patients with pulmonary tuberculosisNonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against InfectionHuman body temperature and new approaches to constructing temperature-sensitive bacterial vaccinesEnhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine.Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis.In vivo and in vitro characterization of murine T-cell clones reactive to Mycobacterium tuberculosisImmune response to atypical mycobacteria: immunocompetence of heavily infected mice measured in vivo fails to substantiate immunosuppression data obtained in vitro.Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.T-cell immune responses in Mycobacterium avium-infected mice.Memory T cell-mediated resistance to Mycobacterium tuberculosis infection in innately susceptible and resistant mice.Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis.Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines.Genetic control of natural resistance to nontuberculous mycobacterial infections in mice.Immunosuppressive effect of cyclosporin A on Mycobacterium bovis BCG infections in mice.
P2860
Q28478603-F603B19F-0260-44FA-9F49-922813D42CF5Q33383180-1D64E848-15F7-4AA1-9DDF-D4E23362AE56Q33683408-2608FE77-2EC9-4F7C-96D9-A18BDA683883Q33747601-03AD1C76-32C1-4B24-8732-477EDFBF6886Q33768651-5B527518-140F-45BA-882A-74CD07598D62Q33934027-8EC01B40-3FAA-4A70-B328-B0B4C89C5D0DQ34000497-F237EF6B-21EA-40CE-870C-118531FB92A8Q34002304-C2FDDAB7-8CC6-49A5-AD64-E527EE425F65Q34006455-C0ACB073-DB9F-4757-9B88-147DED83F115Q34034191-FABFFA98-1AEF-4D8C-88B5-486A0934CA5CQ34126301-0D30D9A2-799C-4244-892B-DC7B1759A6A6Q34344946-99963DA9-ACFD-497C-B7F1-BD58DB05500EQ34528106-A6B556D6-8285-447D-8E87-D08319025D09Q34629227-D4AABFB7-E7D0-41C6-A76D-6AF3E4104047Q34737143-6DE4FE8C-405A-4831-9B36-23778E30C112Q34982062-2DFF5ACD-3CCA-4120-9684-4E77FD7B5F02Q35065531-33932B14-499C-42E6-B7B3-EF31DAABFAADQ35090201-8601ACE8-CF5E-4977-9EDA-92C2BE20A586Q35097409-71EE6C47-3D36-44A1-B279-40A32E85D516Q35099713-14091F96-CACD-430D-AEA9-6498F602FC51Q35165161-BD00DA2D-9E7E-4EEE-9DED-9C52A0F142BFQ35165361-65CB2224-B7CB-4F97-A039-6FA9070BE71FQ35502119-4C3DBE9E-3F6C-4CAC-BE0A-19F1953B2C4EQ35647253-87C242A1-08F6-4409-A602-F83208A9ADE1Q35782886-4CBD376D-8411-402E-977F-131EF13C4EC7Q35910449-28E89407-1A2F-4B14-9C22-58E8BF32885AQ36043783-5AD24308-6330-4EBF-9058-79E218F450E8Q36108268-9BD294B4-28CB-42D2-AFA3-68C65AE8D2B7Q36302781-3211742A-D3F2-4319-B167-42D27826E021Q36367900-7234A9AC-10DD-4530-B9EB-5139630C57A8Q36432208-15A6270D-F759-4990-9BB6-11DB3DEF9B2AQ36623436-1570CF77-AE39-4549-BF1D-AB5611BF19ECQ36635613-C6DB73F5-B632-46F4-8B9D-4EBF96455A66Q36736465-E858905B-DBC8-4547-8DE2-7FEA7D90167AQ36954122-D2FE1474-6286-4F91-857A-D255623F5322Q36964757-D5E611AF-40CC-437B-8DC3-839178222C75Q36971066-80608A18-3103-41C7-A9CD-56660B60852DQ37002893-5ED301B3-B86E-4578-83EE-34844B095399Q37011897-A0E605E4-06C9-4276-A815-B2BC76816104Q37021214-CD1828A6-BCD9-4964-9F53-96F461BAC990
P2860
Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Protection against Mycobacteri ...... r T cell-deficient recipients.
@ast
Protection against Mycobacteri ...... r T cell-deficient recipients.
@en
type
label
Protection against Mycobacteri ...... r T cell-deficient recipients.
@ast
Protection against Mycobacteri ...... r T cell-deficient recipients.
@en
prefLabel
Protection against Mycobacteri ...... r T cell-deficient recipients.
@ast
Protection against Mycobacteri ...... r T cell-deficient recipients.
@en
P2860
P921
P356
P1476
Protection against Mycobacteri ...... r T cell-deficient recipients.
@en
P2093
P2860
P356
10.1084/JEM.158.1.74
P407
P577
1983-07-01T00:00:00Z